GILEAD SCIENCES, INC. Operating Income
GILEAD SCIENCES, INC. (GILD) reported Operating Income of -$10.39 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- GILEAD SCIENCES, INC. operating income (loss) for the quarter ending 2026-06-30 was -$10.39B, a 520.13% decline year-over-year.
- GILEAD SCIENCES, INC. operating income (loss) for the quarter ending 2026-03-31 was $2.59B, a 15.60% increase year-over-year.
- GILEAD SCIENCES, INC. operating income (loss) for the quarter ending 2025-12-31 was $1.98B, a 19.09% decline year-over-year.
- GILEAD SCIENCES, INC. operating income (loss) for the quarter ending 2025-09-30 was $3.33B, a 274.66% increase year-over-year.
- GILEAD SCIENCES, INC. operating income (loss) for fiscal 2025 was $10.02B, a 503.01% increase from fiscal 2024.
- GILEAD SCIENCES, INC. operating income (loss) for fiscal 2024 was $1.66B, a 78.15% decline from fiscal 2023.
- GILEAD SCIENCES, INC. operating income (loss) for fiscal 2023 was $7.61B, a 3.75% increase from fiscal 2022.
- GILEAD SCIENCES, INC. operating income (loss) for fiscal 2022 was $7.33B, a 26.09% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$10.39B 10-Q · filed 2026-08-06 | -$7.81B 10-Q · filed 2026-08-06 | -$5.82B derived: sum of 3 quarters · filed 2026-08-06 | -$2.50B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $2.59B 10-Q · filed 2026-05-07 | $4.57B derived: sum of 2 quarters · filed 2026-05-07 | $7.90B derived: sum of 3 quarters · filed 2026-05-07 | $10.37B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.98B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.31B derived: sum of 2 quarters · filed 2026-02-24 | $7.79B derived: sum of 3 quarters · filed 2026-08-06 | $10.02B 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $3.33B 10-Q · filed 2025-11-07 | $5.80B derived: sum of 2 quarters · filed 2026-08-06 | $8.04B 10-Q · filed 2025-11-07 | $10.49B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.47B 10-Q · filed 2026-08-06 | $4.71B 10-Q · filed 2026-08-06 | $7.16B derived: sum of 3 quarters · filed 2026-08-06 | $8.05B derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $2.24B 10-Q · filed 2026-05-07 | $4.69B derived: sum of 2 quarters · filed 2026-05-07 | $5.58B derived: sum of 3 quarters · filed 2026-05-07 | $8.22B derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $2.45B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.34B derived: sum of 2 quarters · filed 2026-02-24 | $5.98B derived: sum of 3 quarters · filed 2026-02-24 | $1.66B 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $888.00M 10-Q · filed 2025-11-07 | $3.53B derived: sum of 2 quarters · filed 2025-11-07 | -$790.00M 10-Q · filed 2025-11-07 | $822.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $2.64B 10-Q · filed 2025-08-07 | -$1.68B 10-Q · filed 2025-08-07 | -$66.00M derived: sum of 3 quarters · filed 2026-02-24 | $2.56B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$4.32B 10-Q · filed 2025-05-07 | -$2.71B derived: sum of 2 quarters · filed 2026-02-24 | -$87.00M derived: sum of 3 quarters · filed 2026-02-24 | $1.58B derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $1.61B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $4.24B derived: sum of 2 quarters · filed 2026-02-24 | $5.90B derived: sum of 3 quarters · filed 2026-02-24 | $7.61B 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $2.62B 10-Q · filed 2024-11-12 | $4.29B derived: sum of 2 quarters · filed 2024-11-12 | $5.99B 10-Q · filed 2024-11-12 | $8.26B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-06-30 | $1.67B 10-Q · filed 2024-08-08 | $3.37B 10-Q · filed 2024-08-08 | $5.64B derived: sum of 3 quarters · filed 2025-02-28 | $8.47B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2023-03-31 | $1.71B 10-Q · filed 2024-05-08 | $3.97B derived: sum of 2 quarters · filed 2025-02-28 | $6.81B derived: sum of 3 quarters · filed 2025-02-28 | $8.84B derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $2.27B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $5.10B derived: sum of 2 quarters · filed 2025-02-28 | $7.13B derived: sum of 3 quarters · filed 2025-02-28 | $7.33B 10-K · filed 2025-02-28 | ||||
| 2022-09-30 | $2.84B 10-Q · filed 2023-11-07 | $4.87B derived: sum of 2 quarters · filed 2023-11-07 | $5.06B 10-Q · filed 2023-11-07 | $6.00B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-06-30 | $2.03B 10-Q · filed 2023-08-04 | $2.23B 10-Q · filed 2023-08-04 | $3.17B derived: sum of 3 quarters · filed 2024-02-23 | $7.01B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2022-03-31 | $197.00M 10-Q · filed 2023-05-03 | $1.14B derived: sum of 2 quarters · filed 2024-02-23 | $4.98B derived: sum of 3 quarters · filed 2024-02-23 | $7.22B derived: sum of 4 quarters · filed 2024-02-23 | ||||
| 2021-12-31 | $940.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $4.78B derived: sum of 2 quarters · filed 2024-02-23 | $7.03B derived: sum of 3 quarters · filed 2024-02-23 | $9.92B 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | $3.84B 10-Q · filed 2022-11-02 | $6.09B derived: sum of 2 quarters · filed 2022-11-02 | $8.98B 10-Q · filed 2022-11-02 | $11.63B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | $2.25B 10-Q · filed 2022-08-08 | $5.14B 10-Q · filed 2022-08-08 | $7.79B derived: sum of 3 quarters · filed 2023-02-22 | $9.79B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $2.89B 10-Q · filed 2022-05-04 | $5.54B derived: sum of 2 quarters · filed 2023-02-22 | $7.54B derived: sum of 3 quarters · filed 2023-02-22 | $4.56B derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | $2.65B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $4.65B derived: sum of 2 quarters · filed 2023-02-22 | $1.67B derived: sum of 3 quarters · filed 2023-02-22 | $4.07B 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | $2.00B 10-Q · filed 2021-11-03 | -$982.00M derived: sum of 2 quarters · filed 2021-11-03 | $1.42B 10-Q · filed 2021-11-03 | $2.51B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$2.98B 10-Q · filed 2021-08-05 | -$581.00M 10-Q · filed 2021-08-05 | $512.00M derived: sum of 3 quarters · filed 2022-02-23 | -$961.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | $2.40B 10-Q · filed 2021-05-06 | $3.50B derived: sum of 2 quarters · filed 2022-02-23 | $2.02B derived: sum of 3 quarters · filed 2022-02-23 | $4.45B derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $1.09B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | -$380.00M derived: sum of 2 quarters · filed 2022-02-23 | $2.05B derived: sum of 3 quarters · filed 2022-02-23 | $4.29B 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | -$1.47B 10-Q · filed 2020-11-04 | $957.00M derived: sum of 2 quarters · filed 2020-11-04 | $3.19B 10-Q · filed 2020-11-04 | $4.34B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $2.43B 10-Q · filed 2020-08-06 | $4.67B 10-Q · filed 2020-08-06 | $5.81B derived: sum of 3 quarters · filed 2021-02-25 | $8.43B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $2.24B 10-Q · filed 2020-05-06 | $3.38B derived: sum of 2 quarters · filed 2021-02-25 | $6.00B derived: sum of 3 quarters · filed 2021-02-25 | $8.28B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $1.14B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.77B derived: sum of 2 quarters · filed 2021-02-25 | $6.05B derived: sum of 3 quarters · filed 2021-02-25 | $8.20B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $2.62B 10-Q · filed 2019-11-05 | $4.90B derived: sum of 2 quarters · filed 2019-11-05 | $7.06B 10-Q · filed 2019-11-05 | $9.35B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | $2.28B 10-Q · filed 2019-08-06 | $4.43B 10-Q · filed 2019-08-06 | $6.72B derived: sum of 3 quarters · filed 2020-02-25 | $10.54B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | $2.15B 10-Q · filed 2019-05-08 | $4.44B derived: sum of 2 quarters · filed 2020-02-25 | $8.26B derived: sum of 3 quarters · filed 2020-02-25 | $12.51B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $2.29B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $6.10B derived: sum of 2 quarters · filed 2020-02-25 | $10.36B derived: sum of 3 quarters · filed 2020-02-25 | $14.12B 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $3.81B 10-Q · filed 2018-11-06 | $8.07B derived: sum of 2 quarters · filed 2018-11-06 | $11.83B 10-Q · filed 2018-11-06 | $15.88B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $4.25B 10-Q · filed 2018-08-06 | $8.02B 10-Q · filed 2018-08-06 | $12.07B derived: sum of 3 quarters · filed 2019-02-26 | $16.46B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | $3.77B 10-Q · filed 2018-05-09 | $7.81B derived: sum of 2 quarters · filed 2019-02-26 | $12.21B derived: sum of 3 quarters · filed 2019-02-26 | $16.75B derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | $4.04B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.44B derived: sum of 2 quarters · filed 2019-02-26 | $12.98B derived: sum of 3 quarters · filed 2019-02-26 | $17.63B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $4.40B 10-Q · filed 2017-11-07 | $8.94B derived: sum of 2 quarters · filed 2017-11-07 | $13.59B 10-Q · filed 2017-11-07 | $19.21B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $4.54B 10-Q · filed 2017-08-07 | $9.19B 10-Q · filed 2017-08-07 | $14.81B derived: sum of 3 quarters · filed 2018-02-27 | $20.39B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $4.65B 10-Q · filed 2017-05-10 | $10.27B derived: sum of 2 quarters · filed 2018-02-27 | $15.86B derived: sum of 3 quarters · filed 2018-02-27 | $21.47B derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $5.62B derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $11.21B derived: sum of 2 quarters · filed 2018-02-27 | $16.82B derived: sum of 3 quarters · filed 2018-02-27 | $22.19B 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | $5.58B 10-Q · filed 2016-11-07 | $11.20B derived: sum of 2 quarters · filed 2016-11-07 | $16.57B 10-Q · filed 2016-11-07 | $20.90B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $5.62B 10-Q · filed 2016-08-05 | $10.99B 10-Q · filed 2016-08-05 | $15.32B derived: sum of 3 quarters · filed 2017-02-27 | $18.80B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $5.37B 10-Q · filed 2016-05-06 | $9.70B derived: sum of 2 quarters · filed 2017-02-27 | $13.18B derived: sum of 3 quarters · filed 2017-02-27 | $17.59B derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $4.33B derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $7.81B derived: sum of 2 quarters · filed 2017-02-27 | $12.22B derived: sum of 3 quarters · filed 2017-02-27 | $15.27B 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $3.48B 10-Q · filed 2015-11-04 | $3.48B 10-Q · filed 2014-11-05 | $7.89B derived: sum of 2 quarters · filed 2015-11-04 | $10.94B 10-Q · filed 2015-11-04 | $10.93B 10-Q · filed 2014-11-05 | $12.13B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $4.41B 10-Q · filed 2015-08-05 | $4.41B 10-Q · filed 2014-08-04 | $7.46B 10-Q · filed 2015-08-05 | $7.46B 10-Q · filed 2014-08-04 | $8.65B derived: sum of 3 quarters · filed 2016-02-24 | $9.80B derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $3.04B 10-Q · filed 2015-05-08 | $3.04B 10-Q · filed 2014-05-07 | $4.24B derived: sum of 2 quarters · filed 2016-02-24 | $5.39B derived: sum of 3 quarters · filed 2016-02-24 | $6.54B derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $1.20B derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $2.34B derived: sum of 2 quarters · filed 2016-02-24 | $3.50B derived: sum of 3 quarters · filed 2016-02-24 | $4.52B 10-K · filed 2016-02-24 | $4.52B 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $1.15B 10-Q · filed 2014-11-05 | $2.30B derived: sum of 2 quarters · filed 2014-11-05 | $3.33B 10-Q · filed 2014-11-05 | $4.43B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $1.15B 10-Q · filed 2014-08-04 | $2.18B 10-Q · filed 2014-08-04 | $3.29B derived: sum of 3 quarters · filed 2015-02-25 | $4.33B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $1.03B 10-Q · filed 2014-05-07 | $2.13B derived: sum of 2 quarters · filed 2015-02-25 | $3.18B derived: sum of 3 quarters · filed 2015-02-25 | $4.24B derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $1.11B derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $2.15B derived: sum of 2 quarters · filed 2015-02-25 | $3.21B derived: sum of 3 quarters · filed 2015-02-25 | $4.01B 10-K · filed 2015-02-25 | $4.01B 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $1.04B 10-Q · filed 2013-10-31 | $2.10B derived: sum of 2 quarters · filed 2013-10-31 | $2.90B 10-Q · filed 2013-10-31 | $3.77B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | $1.06B 10-Q · filed 2013-08-01 | $1.86B 10-Q · filed 2013-08-01 | $2.73B derived: sum of 3 quarters · filed 2014-02-25 | $3.73B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | $800.19M 10-Q · filed 2013-05-08 | $1.67B derived: sum of 2 quarters · filed 2014-02-25 | $2.67B derived: sum of 3 quarters · filed 2014-02-25 | $3.69B derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $867.48M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $1.87B derived: sum of 2 quarters · filed 2014-02-25 | $2.89B derived: sum of 3 quarters · filed 2014-02-25 | $3.79B 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $1.00B 10-Q · filed 2012-11-06 | $2.02B derived: sum of 2 quarters · filed 2012-11-06 | $2.92B 10-Q · filed 2012-11-06 | $3.75B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $1.02B 10-Q · filed 2012-08-01 | $1.92B 10-Q · filed 2012-08-01 | $2.75B derived: sum of 3 quarters · filed 2013-02-27 | $3.73B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $901.97M 10-Q · filed 2012-05-04 | $1.73B derived: sum of 2 quarters · filed 2013-02-27 | $2.71B derived: sum of 3 quarters · filed 2013-02-27 | $3.70B derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | $829.38M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $1.81B derived: sum of 2 quarters · filed 2013-02-27 | $2.80B derived: sum of 3 quarters · filed 2013-02-27 | $3.96B 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $979.07M 10-Q · filed 2011-11-04 | $1.97B derived: sum of 2 quarters · filed 2011-11-04 | $3.13B 10-Q · filed 2011-11-04 | $4.20B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | $992.63M 10-Q · filed 2011-08-05 | $2.15B 10-Q · filed 2011-08-05 | $3.22B derived: sum of 3 quarters · filed 2012-02-23 | $4.11B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | $1.16B 10-Q · filed 2011-05-09 | $2.23B derived: sum of 2 quarters · filed 2012-02-23 | $3.12B derived: sum of 3 quarters · filed 2012-02-23 | $3.88B derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $1.07B derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $1.96B derived: sum of 2 quarters · filed 2012-02-23 | $2.72B derived: sum of 3 quarters · filed 2012-02-23 | $3.53B 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $894.41M 10-Q · filed 2010-11-08 | $1.66B derived: sum of 2 quarters · filed 2010-11-08 | $2.46B 10-Q · filed 2010-11-08 | $3.17B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | $761.06M 10-Q · filed 2010-08-09 | $1.57B 10-Q · filed 2010-08-09 | $2.28B derived: sum of 3 quarters · filed 2011-02-28 | $2.97B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $808.32M 10-Q · filed 2010-05-10 | $1.52B derived: sum of 2 quarters · filed 2011-02-28 | $2.21B derived: sum of 3 quarters · filed 2011-02-28 | $2.82B derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2008-12-31 | $711.15M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $1.40B derived: sum of 2 quarters · filed 2011-02-28 | $2.01B derived: sum of 3 quarters · filed 2011-02-28 | $2.68B 10-K · filed 2011-02-28 | ||||
| 2008-09-30 | $693.83M 10-Q · filed 2009-11-05 | $1.30B derived: sum of 2 quarters · filed 2009-11-05 | $1.97B 10-Q · filed 2009-11-05 | |||||
| 2008-06-30 | $605.51M 10-Q · filed 2009-08-05 | $1.27B 10-Q · filed 2009-08-05 | ||||||
| 2007-12-31 | $2.16B 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |